Zobrazeno 1 - 6
of 6
pro vyhledávání: '"schizophrenia cognition rating scale"'
Autor:
Mahin Eslami Shahrbabaki, Delaram Barfehie, Shahrzad Mazhari, Atefeh Ahmadi, Shahideh Shafiee
Publikováno v:
Addiction and Health, Vol 14, Iss 4, Pp 239-43 (2023)
Background: There are similar findings about the similarities and differences of cognitive dysfunctions in patients with schizophrenia and methamphetamine-induced psychosis (MIP). This study aimed to compare cognitive functioning in schizophrenia and
Externí odkaz:
https://doaj.org/article/bae28953efcd455c89bbe477f4e348c1
Autor:
Daiki Sasabayashi, Yuko Higuchi, Haruko Kobayashi, Yoichiro Takayanagi, Atsushi Furuichi, Kyo Noguchi, Shimako Nishiyama, Michio Suzuki, Tien Viet Pham, Tsutomu Takahashi, Yukiko Akasaki, Yuko Mizukami
Publikováno v:
NeuroImage : Clinical
NeuroImage: Clinical, Vol 32, Iss, Pp 102805-(2021)
NeuroImage: Clinical, Vol 32, Iss, Pp 102805-(2021)
Highlights • Pineal morphology was investigated in schizophrenia patients and ARMS subjects. • Pineal volumes were significantly smaller in both groups than in healthy controls. • Pineal cysts were associated with clinical symptomatology in sch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4d84f573bcfd30849778fed97741af
https://doi.org/10.1016/j.nicl.2021.102805
https://doi.org/10.1016/j.nicl.2021.102805
Autor:
Tsutomu Takahashi, Shimako Nishiyama, Yuko Komori, Michio Suzuki, Yuko Higuchi, Tomiki Sumiyoshi, Motomu Suga, Kiyoto Kasai, Tomonori Seo
Publikováno v:
Schizophrenia Research: Cognition
Schizophrenia Research: Cognition, Vol 7, Iss C, Pp 13-18 (2017)
Schizophrenia Research: Cognition, Vol 7, Iss C, Pp 13-18 (2017)
Cognitive function is impaired in patients with schizophrenia-spectrum disorders, even in their prodromal stages. Specifically, the assessment of cognitive abilities related to daily-living functioning, or functional capacity, is important to predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::befd846c085dfa65f2a52db0443994f9
https://pubmed.ncbi.nlm.nih.gov/28740824
https://pubmed.ncbi.nlm.nih.gov/28740824
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eslami Shahrbabaki M; Neuroscience Research Center and Institute of Neuropharmacology, Psychiatry Department, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran., Barfehie D; Neurology Research Center, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran., Mazhari S; Neuroscience Research Center and Institute of Neuropharmacology, Psychiatry Department, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran., Ahmadi A; Social Determinants of Health Research Center, Institute for Futures Studies in Health, Department of Counselling in Midwifery, Kerman University of Medical Sciences, Kerman, Iran., Shafiee S; Psychiatry Department, Neurology Research Center, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Publikováno v:
Addiction & health [Addict Health] 2022 Oct; Vol. 14 (4), pp. 239-243. Date of Electronic Publication: 2022 Oct 29.
Autor:
Higuchi Y; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Sumiyoshi T; Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Japan., Seo T; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Suga M; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Japan.; Department of Rehabilitation, The University of Tokyo Hospital, Japan., Takahashi T; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Nishiyama S; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Komori Y; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Kasai K; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Japan., Suzuki M; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan.
Publikováno v:
Schizophrenia research. Cognition [Schizophr Res Cogn] 2017 Feb 22; Vol. 7, pp. 13-18. Date of Electronic Publication: 2017 Feb 22 (Print Publication: 2017).